The research, led by Siqi Chen and Lihua Hou of Central South University in Changsha, China, together with colleagues at the Institute of Forensic Science in Beijing and Hebei Medical University, focused on a specific and stubborn forensic problem: pulp-free teeth. When a tooth loses its pulp, whether through decay, treatment, or postmortem degradation, investigators lose the soft tissue that normally yields abundant, high-quality DNA. What remains are the hard mineralized tissues, dentin and cementum, which preserve DNA remarkably well over time but have been difficult to exploit for age prediction. The team set out to determine whether DNA methylation patterns in these hard tissues could still encode a person’s chronological age with usable precision.

DNA methylation is a chemical modification in which methyl groups attach to cytosine bases at specific positions in the genome, known as CpG sites. Across a person’s lifetime, the pattern of these modifications changes in a systematic, tissue-dependent way, a phenomenon that underlies the so-called epigenetic clock first described by Steve Horvath in 2013. Because methylation is chemically stable and can be measured even in degraded DNA, it has become one of the most promising molecular approaches to forensic age estimation. Previous studies have built methylation-based age predictors from blood, saliva, bone, and dental pulp, but pulp-free teeth remained a gap in the forensic toolkit.

To close that gap, the researchers prioritized ten previously reported age-associated CpG loci that had already been validated in skeletal and dental tissues. They then constructed their study around 128 sectioned, pulp-free teeth, treating the cut samples as simulated forensic specimens. Before building any predictive model, the team asked a critical methodological question: do the type of tooth or the sex of the individual distort the relationship between methylation and age? Using analysis of variance-based interaction testing, they found that neither factor significantly modified the methylation-age relationship, with P values of 0.340 for tooth type and 0.468 for sex. Adding interaction terms for either variable also failed to reduce prediction error meaningfully, with P values of 0.210 and 0.156 respectively.

That negative result carries real practical weight. If methylation patterns behaved differently in incisors than in molars, or in men than in women, forensic laboratories would need separate models for each category, multiplying complexity and fragmenting limited sample sizes. Instead, the findings support a unified model that can be applied to pulp-free teeth regardless of type or the sex of the donor, simplifying workflows in casework where every scrap of information matters.

With the marker set established, the team compared four statistical approaches for converting methylation values into age estimates: partial least squares regression, ridge regression, elastic net regression, and support vector regression with a radial basis function kernel. Each model’s hyperparameters were optimized through ten-fold cross-validation, a technique that repeatedly splits the data into training and testing subsets to prevent overfitting and to ensure that the model generalizes to samples it has never seen. Overfitting is a persistent danger in forensic model building, where datasets are modest and the temptation to squeeze out every last percentage of accuracy can produce models that collapse on real casework.

The verdict was clear. Ridge regression, a method that deliberately constrains model complexity by shrinking regression coefficients, provided the best balance between fitting the training data and generalizing to new samples. On the test set, it achieved an R-squared of 0.749, meaning it explained roughly three-quarters of the variance in chronological age, with a mean absolute error of 6.112 years. In forensic practice, an average error of about six years is considered useful, particularly for cases where no morphological indicators survive. It is not precise enough to identify an individual, but it can narrow an unidentified person’s age range substantially and corroborate or challenge other evidence.

The study also probed whether removing the pulp itself changes the methylation signal in the remaining hard tissues. In a paired analysis comparing pulp-retained and pulp-free teeth from the same individuals, the researchers found no significant difference in overall prediction error between the two specimen types. One marker, cg22507023, did differ significantly between the groups, a nuance that may merit attention in future marker selection. More broadly, a supplementary validation on paired teeth from different positions in the mouths of twelve randomly selected individuals confirmed that CpG methylation levels and predicted ages did not differ meaningfully within a single person. In other words, it should not matter much which tooth an investigator recovers; the epigenetic signal is consistent across the dentition.

The implications extend beyond routine casework. Teeth are famously durable, surviving fire, decomposition, and millennia of burial better than almost any other human tissue. They are often the only identifiable material recovered from disaster scenes, historical burials, and archaeological contexts. A method that extracts age information from pulp-free dental hard tissues could therefore assist not only forensic identification but also the study of ancient populations, provided the methylation signal survives in sufficiently old material. The technique also complements existing approaches such as Raman spectroscopy of teeth and amino acid racemization, giving investigators a growing menu of molecular options when morphology fails.

Challenges remain before the method becomes standard practice. The study was conducted on a specific population, and methylation-age relationships can vary across ancestries and environments, so independent validation in other cohorts will be essential. The mean absolute error of six years, while useful, still leaves wide uncertainty bands for very young or very old individuals, where age-related methylation changes can plateau. Laboratory costs and processing time must also fall before the approach can be deployed at scale. Nevertheless, the demonstration that sectioned, pulp-free teeth, specimens once considered nearly worthless for molecular age estimation, can yield predictions within about six years of the truth marks a genuine advance. The study was funded by the National Natural Science Foundation of China and regional science foundations, and was approved by the Ethics Committee of Basic Medical Sciences at Central South University. As epigenetic forensics matures, the humble tooth, even one emptied of everything soft and alive, is proving to be a stubborn witness that keeps telling time long after the body has fallen silent.

Subject of Research: DNA methylation-based forensic age estimation from pulp-free teeth

Article Title: Age estimation from DNA methylation in sectioned pulp-free teeth

Article References: Chen, S., Hou, L., Liu, L., Wen, D., Liang, X., Zhang, Y., Chen, B., Zhao, L., Liu, Y., & Zha, L. (2026). Age estimation from DNA methylation in sectioned pulp-free teeth. International Journal of Legal Medicine. https://doi.org/10.1007/s00414-026-04026-2

Image Credits: AI Generated

DOI: 10.1007/s00414-026-04026-2

Keywords: DNA methylation, forensic science, age estimation, teeth, epigenetic clock, CpG sites, ridge regression, forensic anthropology, dental tissue, machine learning, legal medicine, estimation

The research team, led by Dayeon Kang and Jaemin Kim of Gyeongsang National University together with colleagues at the National Institute of Animal Science in Korea and the University of Rennes in France, focused on a deliberately clean experimental design. They studied clinically healthy beagle dogs divided into three distinct age groups, spanning adulthood from young adults to senior animals. Beagles were a strategic choice: as a genetically homogeneous single-breed population raised under controlled conditions, they minimize the confounding effects of breed, ancestry, and environment that plague most studies of aging in outbred populations, whether human or canine. That homogeneity means the molecular signals the team detected are more likely to reflect aging itself rather than background genetic variation.

The technical approach was comprehensive. The researchers performed whole-genome bisulfite sequencing, a method that converts unmethylated cytosines to uracils and thereby allows researchers to read the methylation status of individual CpG sites across the entire genome at base resolution. In parallel, they used RNA sequencing to quantify gene expression in the same animals, generating matched methylome and transcriptome profiles for each dog. DNA methylation, the attachment of methyl groups to cytosine bases at CpG dinucleotides, is a key epigenetic mark that helps determine whether genes are switched on or off, and its gradual alteration with age has become one of the most robust molecular signatures of aging across mammals.

The first major finding was one of stability with a twist. Global methylation levels, the overall fraction of methylated CpG sites across the genome, were highly conserved between individual dogs, even across age groups. The canine methylome, in other words, maintains its broad architecture throughout life. But when the team looked more closely, they found that variability, rather than average levels, was what changed. Both methylation variability and gene expression variability increased progressively as the dogs aged. This phenomenon, known as epigenetic drift, has been described in humans and mice, famously in studies showing that monozygotic twins diverge epigenetically over their lifetimes. The beagle data confirm that drift is not a quirk of laboratory rodents or of human populations exposed to decades of heterogeneous environments; it occurs even in genetically uniform dogs living under controlled conditions.

Crucially, the drift was not stochastic in the loose sense of being directionless. When the researchers examined where in the genome the increasing variability was concentrated, they found it was structured by genomic context. The relationship between CpG methylation and the expression of nearby genes weakened with age, indicating a gradual loss of epigenetic control over transcription. In a young animal, methylation at regulatory CpG sites acts as a reasonably reliable predictor of gene activity; in older animals, that coupling loosens. This decoupling suggests that aging erodes the precision of the regulatory machinery that links chemical marks on DNA to the output of the transcriptional apparatus, a finding that resonates with the broader view of aging as a progressive loss of molecular homeostasis and coordination.

Perhaps the most novel contribution of the study is its demonstration that methylation changes unfold in distinct, stage-specific patterns across the three age groups. Rather than a single uniform trajectory, the team identified early-shift patterns, in which methylation changes occur predominantly between the youngest and middle age groups; late-shift patterns, concentrated between the middle and oldest groups; and progressive patterns, in which changes accumulate steadily across the entire adult lifespan. These are not arbitrary categories. When the researchers performed pathway and gene-set enrichment analyses on the genes associated with each pattern, the groups showed partially overlapping but clearly distinct associations with established hallmarks of aging, the set of conserved biological processes, from genomic instability and telomere attrition to mitochondrial dysfunction and altered intercellular communication, that define mammalian aging.

This staging has important implications. It suggests that different biological programs of aging are switched on, or wind down, at different points of adulthood, and that a single snapshot late in life misses much of the story. It also aligns with recent work in other species. Studies in aging mice have documented nonlinear DNA methylation trajectories, and a 2024 analysis of human multi-omics profiles found that molecular markers of aging do not accumulate linearly but appear to cluster around specific windows, including midlife transitions. The beagle data extend that nonlinear picture to a large companion animal whose lifespan, roughly ten to fifteen years for many breeds, compresses the aging process into a timeframe researchers can actually study.

Dogs have become increasingly prominent in geroscience for exactly this reason. They share our environments, develop many of the same age-related diseases, including cancer, cardiac dysfunction, and cognitive decline, and their larger size and longer lifespan relative to mice make longitudinal studies more tractable in some respects. Previous work established epigenetic clocks for dogs and wolves, demonstrating that methylation-based age estimators translate remarkably well between dogs and humans, and the Dog Aging Project has been building large cohorts of companion dogs to study environmental and genetic determinants of healthy aging. What the new study adds is the integration layer: by pairing methylation with transcriptome data in the same individuals, it moves beyond cataloging age-associated marks to asking what those marks do to gene regulation.

The integrative design also matters for a persistent problem in epigenetic aging research: cellular heterogeneity. Blood, the tissue most commonly sampled in both human and canine studies, is a mixture of cell types whose proportions shift with age, and those shifts can masquerade as methylation changes. By examining methylation-expression relationships directly, the researchers could assess whether age-associated methylation changes actually correspond to altered gene output, providing a functional readout that pure methylation studies lack. The observed weakening of CpG-gene associations with age suggests that part of the methylation signal in older animals reflects genuine regulatory remodeling rather than mere compositional change, although the authors note that accounting for cellular composition remains critical in this field.

The practical payoff could be substantial. Understanding which methylation changes occur early versus late in adulthood could inform the development of better canine epigenetic clocks, ones that capture not just chronological age but biological stage, and could help veterinarians and researchers identify animals undergoing accelerated epigenetic aging before disease manifests. Given that dogs and humans share conserved methylation remodeling with age, the stage-specific patterns identified in beagles may also point to corresponding windows in human aging where interventions, whether dietary, pharmacological, or lifestyle-based, might be most effective. The raw data have been deposited in public repositories, with whole-genome bisulfite sequencing data under accession E-MTAB-15578 and RNA-seq data under E-MTAB-15574, making the resource available to the broader community. As companion dogs continue to emerge as premier models for translational aging research, this study provides both a methodological template and a conceptual map: aging, in dogs as in humans, is a choreographed sequence of regulatory changes, and knowing the choreography is the first step toward changing it.

Subject of Research: Integrative methylome and transcriptome profiling of age-associated epigenetic drift and regulatory remodeling in beagle dogs

Article Title: Integration of methylome and transcriptome reveals age-associated signatures of stage-specific dynamics and regulatory remodeling in dogs

Article References: Integration of methylome and transcriptome reveals age-associated signatures of stage-specific dynamics and regulatory remodeling in dogs. (n.d.). https://doi.org/10.1007/s11357-026-02533-z

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02533-z

Keywords: DNA methylation, epigenetic drift, transcriptome, aging, dogs, beagle, GeroScience, epigenetic clock, gene expression, CpG sites, whole-genome bisulfite sequencing, Integration

DNA methylation is one of the body’s most important epigenetic regulatory systems. It involves the addition or removal of methyl groups at cytosine-phosphate-guanine (CpG) sites along the DNA strand, frequently in promoter regions, and these chemical tags act like volume knobs for gene expression, dialing genes up or down without altering the underlying genetic code. Methylation patterns shift dramatically during periods of physiological upheaval, and pregnancy is no exception. Previous research has documented methylation changes in maternal blood across gestation, including gains of methylation in genes involved in morphogenesis and losses in genes promoting maternal-infant bonding. Other studies have tied methylation shifts to complications such as gestational diabetes and preeclampsia. But a critical question lingered: do these pregnancy-induced changes simply wash away after delivery, or do they endure as a kind of molecular memory?

The research team, led by Su Chen and Miranda Johs of the University of Nebraska Medical Center alongside collaborators at the University of Memphis, University of Southampton, University of Michigan, Michigan State University, and the David Hide Asthma and Allergy Research Centre, was designed to answer exactly that question, and to fix two persistent gaps in the literature. First, most prior studies of parous women, those who have given birth, lacked nulliparous controls, women who have never given birth, making it impossible to isolate the effect of childbearing itself. Second, only a single small pilot study had ever examined whether methylation changes persist beyond the immediate postpartum period. The new work addressed both problems by comparing methylation profiles of parous and nulliparous women at two timepoints in young adulthood, ages 18 and 26, which correspond to pre-pregnancy and at least six months postpartum for the mothers in the sample.

The discovery cohort came from the Isle of Wight (IOW) birth cohort, a three-generation study established in the United Kingdom between 1989 and 1990 to prospectively follow the natural history of asthma and allergy. Of 750 female participants, 144 had DNA methylation measured at both ages 18 and 26, and 89 of those women had childbearing history validated through medical records. Twenty-eight had given birth at least six months before the age-26 measurement, while 61 had not. The researchers screened 389,355 CpG sites, the overlap between the Illumina HumanMethylation450 and MethylationEPIC platforms, using a training-testing screening method called ttScreening, which repeatedly splits samples into training and test sets to filter out uninformative sites. Linear regression analyses followed, adjusting for six blood cell type proportions, residual methylation at age 18, body mass index change, smoking categories, and socioeconomic status.

The result was striking: 184 CpG sites were significantly differentially methylated between parous and nulliparous women after correction for multiple testing. To guard against a cohort-specific fluke, the team pursued replication in an entirely independent population, the ELEMENT cohort from Mexico City, a multi-generation birth cohort of Hispanic women followed for nearly three decades. In the ELEMENT subsample of 54 women, 105 of the 184 CpGs showed regression coefficients pointing in the same direction as the Isle of Wight findings, and 13 of those were statistically significant. Seven of the replicated sites showed lower methylation in parous women and six showed higher methylation, a pattern consistent across both cohorts despite their differences in ethnicity, geography, and age structure. The 13 replicated CpGs mapped to 16 unique genes.

Among those genes, one stands out with particular force: TM2D3, a gene previously implicated in late-onset Alzheimer’s disease through exome-wide association analysis. In the Isle of Wight data, methylation at cg01537571, a site within a CpG island near the transcription start site of TM2D3, was significantly lower in parous women in both cohorts, and methylation at this site correlated positively with gene expression. When the team examined RNA sequencing data from blood samples at age 26, TM2D3 was the only gene among the 16 that showed significantly lower expression in parous compared with nulliparous women. This convergence is provocative given that increased parity has independently been identified as a risk factor for Alzheimer’s disease, hinting that the methylation change at TM2D3 could be one thread connecting reproductive history to neurodegenerative vulnerability.

Another gene of interest is SEMA3A, which encodes semaphorin 3A, a guidance cue signaling molecule that directs developing neurons during embryogenesis and continues to regulate neuroplasticity in adulthood. SEMA3A showed decreased methylation in parous women and appeared in the study’s gene-disease network linked to neoplasms, mental disorders, and reproductive conditions. The gene plays paradoxical roles in cancer: it promotes tumor progression in hepatocellular carcinoma by enhancing proliferation, migration, and invasion, yet acts as a tumor suppressor in head, neck, and breast cancers, where it boosts antitumoral M1 macrophage proliferation and recruits CD8-positive T cells and natural killer cells to repress tumor growth. The authors speculate that lower methylation near the SEMA3A transcription start site in parous women could conceivably relate to their reduced breast cancer risk, though they caution that whether blood methylation mirrors changes in breast tissue remains unknown.

Beyond these two headline genes, the disease association analysis using the DisGeNET database painted a broader picture. Ten of the 16 genes, including SEMA3A, AKAP13, SLC15A2, DOK2, ADAMTS17, ADARB2, NUP37, PLD5, TPK1, and SLC15A3, were most notably linked with neoplasms, mental disorders, and nervous system diseases such as Parkinson’s disease, schizophrenia, and autism, along with substance use disorders. The breadth surprised even the researchers, who had anticipated connections to reproductive cancers but had not expected substance abuse disorders to surface. Gene expression data confirmed that methylation at cg19086905 (ADAMTS17) and cg13375690 (PDE7A) was negatively associated with expression of those genes, providing functional support for at least some of the methylation signals. Notably, several of the identified genes are expressed in the brain, including TM2D3, SLC15A2, PLD5, ADARB2, and PARPBP, while MAP1LC3C, NUP37, and ADAMTS17 are expressed in breast tissue, tissue-specific patterns that may matter enormously for translating blood-based findings into disease mechanisms.

The study’s design carries genuine strengths. Comparing parous women at pre- and post-pregnancy timepoints against matched nulliparous controls in both discovery and replication cohorts is rare, and the six-month minimum postpartum window avoided the transient methylation fluctuations that may have confounded earlier work sampling just two to four days after delivery. Replication across a 98 percent White UK cohort and an all-Hispanic Mexican cohort supports both internal validity and generalizability. Yet the authors are candid about limitations: the parous groups were small, with 28 women in the Isle of Wight and roughly 20 in the ELEMENT analysis; nulliparous status relied on medical records; the duration required for postpartum methylation to stabilize is unknown; and blood serves only as a proxy for changes in other tissues, with roughly half of the identified genes not routinely expressed in whole blood. Factors that change during pregnancy, such as smoking or income, could not be assessed in nulliparous women at comparable times.

Even with those caveats, the implications are considerable. If the methylation changes observed in blood leukocyte DNA reflect parallel epigenetic remodeling in tissues such as the breast or brain, they could furnish a plausible mechanism for how childbearing reshapes a woman’s disease risk across her lifetime, offering a molecular bridge between reproductive history and outcomes ranging from cancer to Alzheimer’s disease. The researchers emphasize that further studies are needed, particularly cohorts with follow-up into later life, to determine whether these parous-related methylation signatures actually predict health outcomes rather than merely accompanying them. For now, the study adds a compelling piece to a growing body of evidence, from brain imaging traces of childbirth to parity-linked dementia risk, that motherhood writes itself into the body in ways science is only beginning to read, one methyl group at a time.

Subject of Research: Persistent effects of childbearing on blood DNA methylation in women

Article Title: Assessing the effect of childbearing on blood DNA methylation through comparison of parous and nulliparous females

Article References: Chen, S., Johs, M., Karmaus, W., Holloway, J. W., Kheirkhah Rahimabad, P., Goodrich, J. M., Peterson, K. E., Dolinoy, D. C., Arshad, S. H., & Ewart, S. (2024). Assessing the effect of childbearing on blood DNA methylation through comparison of parous and nulliparous females. Epigenetics Communications, 4(1), Article 2. https://doi.org/10.1186/s43682-024-00025-9

Image Credits: AI Generated

DOI: 10.1186/s43682-024-00025-9

Keywords: DNA methylation, pregnancy, childbearing, epigenetics, parous, nulliparous, CpG sites, TM2D3, SEMA3A, Alzheimer's disease, breast cancer, Isle of Wight cohort

The study, published in Epigenetics Communications by researchers at Karolinska Institutet and their collaborators in Denmark and the United States, set out to test whether the Illumina Infinium MethylationEPIC v2.0 array could produce high-quality data from archival newborn blood spots using vanishingly small amounts of DNA. This is no trivial challenge. The EPIC v2.0 array, which profiles approximately 937,000 cytosine-phosphate-guanine sites across the genome, officially recommends between 250 and 500 nanograms of DNA as input material. Decades-old dried blood spots, however, typically surrender far less genetic material, often well below 100 nanograms per sample, raising serious doubts about whether the resulting methylation data would be complete, accurate, and free of technical artifacts.

To find out, the team selected seven random samples from individuals born between 1985 and 2003, meaning the blood spots had been stored for periods ranging from 18 to 40 years. The laboratory workflow began with two 3-millimeter punches from each blood spot, which were placed into 96-well plates. Proteins and metabolites were eluted by incubating the punches in phosphate-buffered saline for two hours at room temperature on a rotary shaker, after which DNA was extracted using the Highprep Blood and Tissue DNA kit from MagBio Genomics, processed on an automated Beckman Coulter BioMek I7 liquid handler and eluted in a final volume of 50 microliters. After a portion of the extract was used for genotyping on an Illumina Global Screening Array, the remainder was carried forward to bisulfite conversion and methylation profiling at the National Genomic Infrastructure in Uppsala, part of Science for Life Laboratory.

The DNA volumes recovered from these archival spots ranged from just 19.2 nanograms to 99.2 nanograms, figures dramatically below the manufacturer’s recommended input of 250 nanograms, with the lowest sample representing less than 10 percent of the prescribed amount. Yet when the raw data came back from the array, the results were extraordinary. Probe call rates, the proportion of methylation sites successfully measured in each sample, averaged 99.75 percent at the conventional significance threshold of p less than 0.01, comfortably exceeding the greater than 98 percent benchmark commonly used to define successful probe detection in methylation studies. Coverage remained robust across all seven samples, with between 930,588 and 936,110 probes reliably detected, close to the array’s full complement of sites.

Quality control went well beyond call rates. The researchers examined the balance between methylated and unmethylated signal intensities, a key indicator of whether DNA degradation or processing problems have distorted the underlying signal. All seven samples clustered tightly around expected values, with median methylated intensity spanning a log-two range of 11.34 to 12.07 and median unmethylated intensity between 10.36 and 10.82, and no outliers emerged from the group. The team also calculated pairwise sample-to-sample Pearson correlations across the full set of genome-wide beta values, which ranged from 0.972 to 1.000. Such uniformly high correlations indicate consistent methylation profiles, reproducible processing, and, crucially, the absence of batch effects, a common scourge of microarray experiments that can masquerade as biological signal.

The fundamental structure of the methylation data also held up under scrutiny. Raw beta value distributions displayed the characteristic bimodal pattern expected of high-quality methylation data, with the vast majority of CpG sites falling into clearly methylated or clearly unmethylated classes and relatively few occupying intermediate values. This bimodality was preserved after noob normalization, a preprocessing step implemented in the R Bioconductor package minfi that corrects for background signal and dye bias, and the normalized density curves showed slightly improved alignment across samples. Embedded control probes monitoring bisulfite conversion, staining, hybridization, target removal, extension, and specificity all performed within expected ranges, with negative control signals remaining low and target-removal controls showing appropriately reduced signal compared with hybridization controls, together indicating minimal background fluorescence and efficient chemistry at every step.

The significance of these findings extends far beyond a single national biobank. DNA methylation, the chemical modification of DNA that influences gene activity without altering the underlying sequence, is increasingly recognized as a record of early-life biology and environmental exposure. Because newborn blood spots capture the epigenome at the very beginning of life, the ability to profile them retrospectively gives researchers a unique window into the molecular conditions present at birth, potentially decades before the onset of disease. Previous work had already shown promise: two earlier studies using the older Infinium 450K array achieved correlations exceeding 0.99 between dried blood spot samples and matched frozen blood fractions, and one proof-of-principle study using the HumanMethylation27 BeadChip demonstrated that neonatal blood spots stored for 26 and 28 years produced methylation profiles nearly identical to adult reference samples with only 30 nanograms of DNA. Other evaluations had pushed the EPIC v2.0 array to inputs as low as 1 nanogram, but only with fresh cell line DNA, never with archival clinical material stored at refrigeration temperatures.

What distinguishes the new study is precisely this combination of archival age, real-world storage conditions, and ultra-low input on the current-generation platform. The samples in the analysis had endured 18 to 40 years of refrigerated storage with variable collection dates, and none showed evidence of degradation-related signal imbalance. The authors note that while Kaur and colleagues had previously demonstrated adequate EPIC v2.0 performance with 1-nanogram inputs using fresh DNA, the present results extend those findings to the far more demanding context of decades-old clinical biobank samples, where DNA may be fragmented, chemically modified, or partially degraded by years of storage.

The limitations of the pilot are nonetheless clear and acknowledged by the team. Seven samples cannot establish population-level generalizability, and future work will need to validate these results in larger cohorts with broader demographic representation. Moreover, all samples analyzed had been collected after 1981 and therefore stored under controlled refrigerated conditions. Samples from before 1981, which spent their early years at room temperature, may behave differently and will require separate validation, although encouraging results from dried blood spots stored three to ten years at room temperature using the older 450K platform have been reported by Joo and colleagues and by Walker and colleagues, suggesting that even less favorable storage histories may not be disqualifying.

Even so, the proof of principle is transformative. The Swedish PKU biobank, with its five million-plus samples collected systematically since 1975 under Swedish Biobank Law provisions that permit ethically approved research use, now stands as an invaluable resource for large-scale epigenetic investigation into conditions ranging from neurodevelopmental disorders to cardiovascular and metabolic disease. Neonatal screening biobanks of similar design exist around the world, collectively representing millions of additional archived samples that could become accessible to methylation profiling. The study was approved by the Swedish Ethical Review Authority without individual informed consent, with all data handled in deidentified form in accordance with GDPR and Swedish legislation. For researchers who have long dreamed of tracing the epigenetic origins of disease back to the first days of life, the message of this small but rigorous study is unmistakable: the molecular memory written into a newborn’s blood can survive decades in a cold archive, and modern technology can now read it with remarkable fidelity, even from less than one-tenth of the DNA the platform’s designers thought necessary.

Subject of Research: DNA methylation profiling of archival neonatal dried blood spots using the Illumina MethylationEPIC v2.0 array with ultra-low DNA input

Article Title: Performance of the Illumina Infinium MethylationEPIC v2.0 array with low DNA input from Swedish neonatal dried blood spots

Article References: Brander, G., Karlsson, H., Dalman, C., Bybjerg-Grauholm, J., Crowley, J. J., & Mataix-Cols, D. (2025). Performance of the Illumina Infinium MethylationEPIC v2.0 array with low DNA input from Swedish neonatal dried blood spots. Epigenetics Communications, 5(1), Article 9. https://doi.org/10.1186/s43682-025-00042-2

Image Credits: AI Generated

DOI: 10.1186/s43682-025-00042-2

Keywords: DNA methylation, dried blood spots, MethylationEPIC v2.0, neonatal biobanks, epigenetics, low-input DNA, archival samples, PKU biobank, quality control, Illumina, Swedish biobank, CpG sites